Evidence of in situ cytotoxicity in American cutaneous leishmaniasis

European Journal of Dermatology

Volumn 12, Issue 5, 2002, Pages 449-451

  Machado, Paulo ^a   Kanitakis, Jean ^a   Almeida, Roque ^a   Chalon, Aurelie ^a   Araújo, Cibele ^a   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

American cutaneous leishmaniasis; Cytotoxicity; Immunohistochemistry; Leishmaniasis; NK cells; TIA 1

Indexed keywords

CD56 ANTIGEN; CD8 ANTIGEN; MEGLUMINE ANTIMONATE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; MALE; NATURAL KILLER CELL; SKIN LEISHMANIASIS; SKIN ULCER; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, CD45; ANTIGENS, CD8; ANTIGENS, T-INDEPENDENT; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BRAZIL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036751476     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Barral-Netto M, Machado P, Bittencourt A, Barral A. Recent Advances in the Pathophysiology and Treatment of Human Cutaneous Leishmaniasis. Curr Op Dermatol 1997; 4: 51-8.
2. Llanos-Cuentas EA, Marsden PD, Lago EL, Barreto AC, Cuba CC, Johnson WD. Human mucocutaneous leishmaniasis in Três Braços, Bahia-Brazil. An area of Leishmania braziliensis infection. II Cutaneous disease presentation and evolution. Rev Soc Bras Med Trop 1984; 17: 169-77.
3. Bittencourt AL, Barral-Netto M. Leishmaniasis. In: Doerr W, Seifert G, eds. Tropical Pathology. 2nd ed. Heidelberg: Springer, 1995: 597-651.
4. Carvalho EM, Johnson WD, Barreto E, Marsden PD, Costa JML, Reed S, Rocha H. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol 1985; 135:4144-8.
5. Barral A, Jesus AR, Almeida RP, Carvalho EM, Barral-Netto M, Costa JML, Badaró R, Rocha H, Johnson WD. Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis. Parasite Immunol 1987; 9: 487-97.
6. Pirmez C, Cooper C, Paes-Oliveira M, Schubach A, Torigian VK, Modlin RL. Immunologic responsiveness in American cutaneous leishmaniasis lesions. J Immunol 1990; 145 (9): 3100-4.
7. Reed SG, Badaró R, Masur H, Carvalho EM, Lorenço R, Lisboa A, Teixeira A, Johnson WD, Jones TC. Selection of a skin test antigen for American cutaneous leishmaniasis. Am J Trop Med Hyg 1986; 35: 79-85.
8. Barral A, Almeida RP, de Jesus AR, Neto EM, Santos IA; Johnson Jr W. The relevance of characterizing leishmania from cutaneous lesions. A simple approach for isolation. Mem Inst Oswaldo Cruz 1987; 82: 579.
9. Melby PC, Andrade-Narvaez FJ, Darnell BJ, Valencia-Pacheco G, Tryon W, Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect Immun 1994; 62 (3): 837-42.
10. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998; 31: 143-8.
11. Melby PC, Andrade-Narvaez FJ, Darnell BJ, Valencia-Pacheco G. In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. FEMS Immunol Med Microbiol 1996; 15 (2-3): 101-7.
12. Machado P, Araújo C, da Silva AT, Almeida RP, D'Oliveira Jr A, Bittencourt A, Carvalho EM. Early cutaneous leishmaniasis: failure of early therapy in preventing the development of an ulcer. Clin Infect Dis 2002; 34(12): E69-73.
13. + T lymphocytes. J Immunol 1990; 144: 574-82.
14. Maasho K, Sanchez F, Schurr E, Hailu A, Akuffo H. Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infect Immun 1998; 66: 2698-704.
15. + T cells following secondary infection of mice immune to Leishmania major. Infect Immun 1994; 62(6): 2575-81.
16. Satoskar AR, Stamm LM, Zhang X, Satoskar AA, Okano M, Terhorst C, David JR, Wang B. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. J Immunol 1999; 162: 6747-54.
17. + T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major. J Immunol 2002; 168 (8): 3992-4000.